Datwyler - Pharma Technology Focus | Issue 122

Conscious Innovation. Elevating Quality Control
and Patient Safety.

No Matter What the Future Holds

02/23/2024 22:05:12

Home | Technology transformation
In this issue
Contents
SHL Medical Company Insight
SHL Medical
Datwyler Company Insight
Datwyler
CSafe Global
Briefing
Industry news
The pharma industry briefing
Mimotopes Company Insight
Mimotopes
Comment
Tapping into pharma’s growing opportunities in digital health
Covid-19 Omicron boosters will reinvigorate injectables manufacturing
Implementation of electronic health records will improve the quality of care
Despite benefits, long-acting injectables remain underutilised for schizophrenia
FDA approves Coherus’ Cimerli for DME, with year-long interchangeability exclusivity
UK health data collaboration paves the way to study Long Covid symptoms
Molnar-Institute Company Insight
Molnar-Institute
In Depth
A makeover for NICE: a new look for HTAs in the UK
No drugs for prions: investigating new approaches to alleviate therapeutic scarc
Getting smart with digital pills
Do generics producers have what it takes to tackle complex and specialty drugs?
Decentralised paediatric clinical trials trending up but study execution critica
CMO Moves: Regulatory catalysts for drug manufacturing—August
Biolife Solutions
In Data
Healthtech deals decreased significantly in the pharma industry in H1 2022
North America is seeing a hiring boom in pharmaceutical industry machine learnin
Artificial intelligence mentions decrease in pharma filings in Q2 of 2022
Digital media hiring levels in the pharmaceutical industry rose in June 2022
Events
Next issue

08/22/2022 00:00:00